Immunex, American Home Products deal

IMNX formed a six-person committee to evaluate AHP's offer to purchase the remainder of the Seattle company it does not already own for $14.50 (see BioCentury Nov. 6). The committee is composed of three independent directors and three directors representing IMNX management. Alex. Brown & Sons will act as financial advisor to the committee. ...